专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20130171124A1 Compositions And Methods Of Treating Head And Neck Cancer 有权
标题翻译：治疗头颈癌的组合和方法
公开(公告)号：US20130171124A1
公开(公告)日：2013-07-04
申请号：US13557988
申请日：2012-07-25
申请人： Le Cong , Ann Marie Egloff , Levi A. Garraway , Jennifer Rubin Grandis , Eric S. Lander , Nicholas Stransky , Aaron D. Tward , Feng Zhang
发明人： Le Cong , Ann Marie Egloff , Levi A. Garraway , Jennifer Rubin Grandis , Eric S. Lander , Nicholas Stransky , Aaron D. Tward , Feng Zhang
IPC分类号： A61K38/16 , A61K45/06 , A61K38/46
CPC分类号： A61K38/164 , A61K38/465 , A61K45/06 , A61K48/005 , C07K14/4703 , C07K14/4705 , C07K2319/00 , C07K2319/70 , C07K2319/71 , C07K2319/80 , C12N9/22 , C12N15/907 , C12N2710/20011 , C12N2800/22 , C12N2999/007
摘要： The present invention provides methods related to the treatment of head and neck squamous cell carcinoma (HNSCC) and its associated premalignant lesions. In particular, the invention features methods which may specifically target HNSCC-associated genes and alter gene expression to treat or alleviate a symptom of HNSCC, or its related premalignant lesions. These methods may involve decreasing the function of an HNSCC-associated gene with aberrant gain-of-function; or increasing the function of an HNSCC-associated gene with aberrant loss-of-function.
摘要翻译：本发明提供了与头颈鳞状细胞癌（HNSCC）及其相关的恶化前病变相关的方法。特别地，本发明的特征在于可以特异性靶向HNSCC相关基因并改变基因表达以治疗或缓解HNSCC或其相关的恶化前病变的症状的方法。这些方法可能涉及降低具有异常增殖功能的HNSCC相关基因的功能; 或增加具有异常功能丧失的HNSCC相关基因的功能。

2. 发明授权

US09370551B2 Compositions and methods of treating head and neck cancer 有权
标题翻译：治疗头颈癌的组合物和方法
公开(公告)号：US09370551B2
公开(公告)日：2016-06-21
申请号：US13557988
申请日：2012-07-25
申请人： Le Cong , Ann Marie Egloff , Levi A. Garraway , Jennifer Rubin Grandis , Eric S. Lander , Nicholas Stransky , Aaron D. Tward , Feng Zhang
发明人： Le Cong , Ann Marie Egloff , Levi A. Garraway , Jennifer Rubin Grandis , Eric S. Lander , Nicholas Stransky , Aaron D. Tward , Feng Zhang
IPC分类号： C12N15/85 , A61K38/16 , A61K38/46 , A61K45/06 , C07K14/47 , C12N9/22 , C12N15/90 , A61K48/00
CPC分类号： A61K38/164 , A61K38/465 , A61K45/06 , A61K48/005 , C07K14/4703 , C07K14/4705 , C07K2319/00 , C07K2319/70 , C07K2319/71 , C07K2319/80 , C12N9/22 , C12N15/907 , C12N2710/20011 , C12N2800/22 , C12N2999/007
摘要： The present invention provides methods related to the treatment of head and neck squamous cell carcinoma (HNSCC) and its associated premalignant lesions. In particular, the invention features methods which may specifically target HNSCC-associated genes and alter gene expression to treat or alleviate a symptom of HNSCC, or its related premalignant lesions. These methods may involve decreasing the function of an HNSCC-associated gene with aberrant gain-of-function; or increasing the function of an HNSCC-associated gene with aberrant loss-of-function.
摘要翻译：本发明提供了与头颈鳞状细胞癌（HNSCC）及其相关的恶化前病变相关的方法。特别地，本发明的特征在于可以特异性靶向HNSCC相关基因并改变基因表达以治疗或缓解HNSCC或其相关的恶化前病变的症状的方法。这些方法可能涉及降低具有异常增殖功能的HNSCC相关基因的功能; 或增加具有异常功能丧失的HNSCC相关基因的功能。

3. 发明授权

US09499592B2 Transcription activator-like effectors 有权
标题翻译：转录激活剂样效应物
公开(公告)号：US09499592B2
公开(公告)日：2016-11-22
申请号：US13353662
申请日：2012-01-19
申请人： Feng Zhang , Le Cong , Sriram Kosuri , George M. Church
发明人： Feng Zhang , Le Cong , Sriram Kosuri , George M. Church
IPC分类号： C07K14/195 , C07K14/47
CPC分类号： C07K14/195 , C07K14/4705 , C07K2319/00 , C07K2319/09 , C07K2319/60 , C07K2319/80 , C12P19/34
摘要： Provided herein are compositions, kits and methods useful in the construction of designer transcription activator-like effector (dTALE) polypeptides.
摘要翻译：本文提供了可用于构建设计者转录激活子样效应子（dTALE）多肽的组合物，试剂盒和方法。

4. 发明申请

US20130137174A1 NUCLEOTIDE-SPECIFIC RECOGNITION SEQUENCES FOR DESIGNER TAL EFFECTORS 有权
公开(公告)号：US20130137174A1
公开(公告)日：2013-05-30
申请号：US13604945
申请日：2012-09-06
申请人： Feng Zhang , Le Cong
发明人： Feng Zhang , Le Cong
IPC分类号： C12N5/071
CPC分类号： C12N5/06 , C07K14/03 , C07K14/195 , C07K14/4703 , C07K2319/80 , C12N5/0686 , C12N9/1241 , C12N9/22 , C12N15/635 , C12Q1/6816 , C12Q2522/10
摘要： The invention relates to methods of altering expression of a genomic locus of interest or specifically targeting a genomic locus of interest in an animal cell, which may involve contacting the genomic locus with a non-naturally occurring or engineered composition that includes a deoxyribonucleic acid (DNA) binding polypeptide having a N-terminal capping region, a DNA binding domain comprising at least five or more Transcription activator-like effector (TALE) monomers and at least one or more half-monomers specifically ordered to target the genomic locus of interest, and a C-terminal capping region, wherein the polypeptide includes at least one or more effector domains, and wherein the polypeptide is encoded by and translated from a codon optimized nucleic acid molecule so that the polypeptide preferentially binds to the DNA of the genomic locus.

5. 发明申请

US20140186958A1 ENGINEERING AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS 有权
公开(公告)号：US20140186958A1
公开(公告)日：2014-07-03
申请号：US14105017
申请日：2013-12-12
申请人： Feng Zhang , Le Cong , Randall Jeffrey Platt , Neville Espi Sanjana , Fei Ran
发明人： Feng Zhang , Le Cong , Randall Jeffrey Platt , Neville Espi Sanjana , Fei Ran
IPC分类号： C12N15/85
CPC分类号： C12N15/63 , C12N7/00 , C12N9/22 , C12N15/01 , C12N15/102 , C12N15/1082 , C12N15/85 , C12N15/86 , C12N2320/30 , C12N2740/15043
摘要： The invention provides for engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target sequences. Provided are vectors and vector systems, some of which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors with additional functional domains. Also provided are methods of directing CRISPR complex formation in prokaryotic and eukaryotic cells to ensure enhanced specificity for target recognition and avoidance of toxicity.

6. 发明申请

US20130137173A1 NUCLEOTIDE-SPECIFIC RECOGNITION SEQUENCES FOR DESIGNER TAL EFFECTORS 审中-公开
标题翻译：设计师TAL效应的核素特异性识别序列
公开(公告)号：US20130137173A1
公开(公告)日：2013-05-30
申请号：US13554922
申请日：2012-07-20
申请人： Feng Zhang , Le Cong
发明人： Feng Zhang , Le Cong
IPC分类号： C12N5/071
CPC分类号： C12N15/63
摘要： The invention relates to methods of altering expression of a genomic locus of interest or specifically targeting a genomic locus of interest in an animal cell, which may involve contacting the genomic locus with a non-naturally occurring or engineered composition that includes a deoxyribonucleic acid (DNA) binding polypeptide having a N-terminal capping region, a DNA binding domain comprising at least five or more Transcription activator-like effector (TALE) monomers and at least one or more half-monomers specifically ordered to target the genomic locus of interest, and a C-terminal capping region, wherein the polypeptide includes at least one or more effector domains, and wherein the polypeptide is encoded by and translated from a codon optimized nucleic acid molecule so that the polypeptide preferentially binds to the DNA of the genomic locus.
摘要翻译：本发明涉及改变感兴趣的基因座的表达或特异性靶向动物细胞中的目的基因组的表达的方法，其可能涉及使基因组座位与包含脱氧核糖核酸（DNA）的非天然存在或工程化组合物接触）结合多肽，DNA结合结构域包含至少五个或更多个转录激活子样效应子（TALE）单体和至少一种或多种特异性命令靶向感兴趣的基因组座位的半单体，以及 C端封端区，其中所述多肽包括至少一个或多个效应域，并且其中所述多肽由密码子优化的核酸分子编码和翻译，使得所述多肽优先结合所述基因组座位的DNA。

7. 发明授权

US08450107B1 Nucleotide-specific recognition sequences for designer TAL effectors 有权
标题翻译：设计师TAL效应器的核苷酸特异性识别序列
公开(公告)号：US08450107B1
公开(公告)日：2013-05-28
申请号：US13604945
申请日：2012-09-06
申请人： Feng Zhang , Le Cong
发明人： Feng Zhang , Le Cong
IPC分类号： C12N15/85 , C12N15/00
CPC分类号： C12N5/06 , C07K14/03 , C07K14/195 , C07K14/4703 , C07K2319/80 , C12N5/0686 , C12N9/1241 , C12N9/22 , C12N15/635 , C12Q1/6816 , C12Q2522/10
摘要： The invention relates to methods of altering expression of a genomic locus of interest or specifically targeting a genomic locus of interest in an animal cell, which may involve contacting the genomic locus with a non-naturally occurring or engineered composition that includes a deoxyribonucleic acid (DNA) binding polypeptide having a N-terminal capping region, a DNA binding domain comprising at least five or more Transcription activator-like effector (TALE) monomers and at least one or more half-monomers specifically ordered to target the genomic locus of interest, and a C-terminal capping region, wherein the polypeptide includes at least one or more effector domains, and wherein the polypeptide is encoded by and translated from a codon optimized nucleic acid molecule so that the polypeptide preferentially binds to the DNA of the genomic locus.
摘要翻译：本发明涉及改变感兴趣的基因座的表达或特异性靶向动物细胞中的目的基因组的表达的方法，其可能涉及使基因组座位与包含脱氧核糖核酸（DNA）的非天然存在或工程化组合物接触）结合多肽，DNA结合结构域包含至少五个或更多个转录激活子样效应子（TALE）单体和至少一种或多种特异性命令靶向感兴趣的基因组座位的半单体，以及 C端封端区，其中所述多肽包括至少一个或多个效应域，并且其中所述多肽由密码子优化的核酸分子编码和翻译，使得所述多肽优先结合所述基因组座位的DNA。

8. 发明申请

US20120270273A1 TRANSCRIPTION ACTIVATOR-LIKE EFFECTORS 有权
标题翻译：转录激活剂类效应物
公开(公告)号：US20120270273A1
公开(公告)日：2012-10-25
申请号：US13353662
申请日：2012-01-19
申请人： Feng Zhang , Le Cong , Sriram Kosuri , George M. Church
发明人： Feng Zhang , Le Cong , Sriram Kosuri , George M. Church
IPC分类号： C12N15/62 , C12P19/34 , C12N15/63
CPC分类号： C07K14/195 , C07K14/4705 , C07K2319/00 , C07K2319/09 , C07K2319/60 , C07K2319/80 , C12P19/34
摘要： Provided herein are compositions, kits and methods useful in the construction of designer transcription activator-like effector (dTALE) polypeptides.
摘要翻译：本文提供了可用于构建设计者转录激活子样效应子（dTALE）多肽的组合物，试剂盒和方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式